The DOI matches its Crossref record; 54 of the 56 references it cites were found in a registry or an index.
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Open accessAbstract
Amyloid-β (Aβ) peptides are produced in high amounts during Alzheimer's disease, causing synaptic and memory dysfunction. However, they are also released in lower amounts in normal brains throughout life during synaptic activity. Here we show that low picomolar concentrations of a preparation containing both Aβ 42 monomers and oligomers cause a marked increase of hippocampal long-term potentiation, whereas high nanomolar concentrations lead to the well established reduction of potentiation. Picomolar levels of Aβ 42 also produce a pronounced enhancement of both reference and contextual fear memory. The mechanism of action of picomolar Aβ 42 on both synaptic plasticity and memory involves α7-containing nicotinic acetylcholine receptors. These findings strongly support a model for Aβ effects in which low concentrations play a novel positive, modulatory role on neurotransmission and memory, whereas high concentrations play the well known detrimental effect culminating in dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“studies that shed light on the physiological role of Aβ in non-diseased brains show that Aβ plays a role in synaptic transmission and is involved in learning and memory formation [18–22].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“picomolar concentrations of Aβ are sufficient to stimulate nicotinic receptors and subsequently LTP and learning and memory in healthy rodents (Puzzo et al., 2008, 2012; Morley et al., 2010)”
From Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP (2019) · cites this paper as Puzzo et al., 2008
In the citing paper
“To address this concern, other studies injected picomolar concentrations of Aβ peptides into the mice, which also significantly enhanced synaptic plasticity and memory formation.394”
From Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future (2023) · cites this paper as [394]
In the citing paper
“Remarkably, at sub-nanomolar doses, the effect on LTP is reversed, and Aβ markedly enhances LTP. Discovered by Arancio and colleagues in a detailed analysis (Puzzo et al., 2008), enhancement occurs over a narrow range of concentrations and is associated with presynaptic activation of alpha7 nicotinic receptors.”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Puzzo et al., 2008
In the citing paper
“and synaptic transmission (Puzzo et al., 2008, 2011)”
From Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP (2019) · cites this paper as Puzzo et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
Short-Term Synaptic Plasticity
Zucker, R. S., & Regehr, W. G. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.092501.114547 · Cited by 5,068
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning.
Phillips, R. G., & LeDoux, J. E. (1992) · Behavioral Neuroscience · doi:10.1037/0735-7044.106.2.274 · Cited by 3,292
mouse brain in stereotaxic coordinates
Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265
A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60
Cao, X., & Südhof, T. C. (2001) · Science · doi:10.1126/science.1058783 · Cited by 1,202
Research works printed but not linked: 2
- 1985, Exp Brain Res, 58, 11
- 2005, Methods Mol Biol, 299, 279
Cited by
Sorted by citations
Items 201–300 of 740
Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer’s disease
Bordji, K., Becerril-Ortega, J., & Buisson, A. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.029 · Cited by 75
Hormesis in Health and Chronic Diseases
Li, X., Yang, T., & Sun, Z. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.08.007 · Cited by 79
Gulisano, W., Melone, M., Puma, D. D. L., Tropea, M. R., Palmeri, A., Arancio, O., Grassi, C., Conti, F., & Puzzo, D. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.025 · Cited by 72
Self-citationLiu, B., Shen, H., Hao, Y., Zhu, X., Li, S., Huang, Y., Qu, P., & Xu, M. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01546 · Cited by 73
Effects of the duration of hyperlipidemia on cerebral lipids, vessels and neurons in rats
Yang, W., Shi, H., Zhang, J., Shen, Z., Zhou, G., & Hu, M. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-016-0401-6 · Cited by 72
An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?
Sciaccaluga, M., Megaro, A., Bellomo, G., Ruffolo, G., Romoli, M., Palma, E., & Costa, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115991 · Cited by 70
MAPK, β-amyloid and synaptic dysfunction: the role of RAGE
Origlia, N., Arancio, O., Domenici, L., & Yan, S. S. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.107 · Cited by 71
Self-citationLinking pathways in the developing and aging brain with neurodegeneration
Kovács, G. G., Adle‐Biassette, H., Milenković, I., Cipriani, S., van Scheppingen, J., & Aronica, E. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.045 · Cited by 69
Armato, U., Chiarini, A., Chakravarthy, B., Chioffi, F., Pacchiana, R., Colarusso, E., Whitfield, J. F., & Dal Prà, I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.020 · Cited by 68
Körte, M., Herrmann, U., Zhang, X., & Draguhn, A. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2894-6 · Cited by 69
Revisiting the role of brain and peripheral Aβ in the pathogenesis of Alzheimer's disease
Uddin, M. S., Kabir, M. T., Tewari, D., Mamun, A. A., Mathew, B., Aleya, L., Barreto, G. E., Bin-Jumah, M. N., Abdel‐Daim, M. M., & Ashraf, G. M. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116974 · Cited by 70
Caspases in Alzheimer’s Disease: Mechanism of Activation, Role, and Potential Treatment
Wójcik, P., Jastrzębski, M. K., Zięba, A., Matosiuk, D., & Kaczor, A. A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03847-1 · Cited by 78
Fyn, a Potential Target for Alzheimer's Disease
Yang, K., Belrose, J. C., Trepanier, C. H., Lei, G., Jackson, M. F., & MacDonald, J. F. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110353 · Cited by 67
cAMP, cGMP and Amyloid β: Three Ideal Partners for Memory Formation
Ricciarelli, R., & Fedele, E. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.02.001 · Cited by 70
What is the Physiological Function of Amyloid-Beta Protein?
Morley, J. E., Farr, S. A., Nguyen, A. D., & Xu, F. (2019) · The journal of nutrition health & aging · doi:10.1007/s12603-019-1162-5 · Cited by 66
Impairments of glutamatergic synaptic transmission in Alzheimer’s disease
Zott, B., & Konnerth, A. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.03.013 · Cited by 66
Mura, E., Zappettini, S., Preda, S., Biundo, F., Lanni, C., Grilli, M., Cavallero, A., Olivero, G., Salamone, A., Govoni, S. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029661 · Cited by 65
Prete, D. D., Lombino, F. L., Liu, X., & D'adamio, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108576 · Cited by 62
SUMO1 Affects Synaptic Function, Spine Density and Memory
Matsuzaki, S., Lee, L., Knock, E., Srikumar, T., Sakurai, M., Hazrati, L., Katayama, T., Staniszewski, A., Raught, B., Arancio, O., et al. (2015) · Scientific Reports · doi:10.1038/srep10730 · Cited by 66
Self-citationKoppensteiner, P., Trinchese, F., Fà, M., Puzzo, D., Gulisano, W., Yan, S., Poussin, A., Liu, S., Orozco, I. J., Dale, E., et al. (2016) · Scientific Reports · doi:10.1038/srep32553 · Cited by 67
Self-citationIntracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer’s Disease
Perdigão, C., Barata, M. A., Araújo, M. N. C. D. F., Mirfakhar, F. S., Castanheira, J., & Almeida, C. G. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00072 · Cited by 66
Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases
Yeo, X. Y., Cunliffe, G., Ho, R., Lee, S. S., & Jung, S. (2022) · Biomedicines · doi:10.3390/biomedicines10020343 · Cited by 66
Tyr682 in the Intracellular Domain of APP Regulates Amyloidogenic APP Processing In Vivo
Barbagallo, A., Weldon, R., Tamayev, R., Zhou, D., Giliberto, L., Foreman, O., & D'adamio, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015503 · Cited by 66
Nag, S., Chen, J., Irudayaraj, J., & Maiti, S. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.07.020 · Cited by 66
The functional neurophysiology of the amyloid precursor protein (APP) processing pathway
Randall, A. D., Witton, J., Booth, C., Hynes-Allen, A. M., & Brown, J. T. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.011 · Cited by 66
An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice
Frost, J. L., Liu, B., Rahfeld, J., Kleinschmidt, M., O’Nuallain, B., Le, K. X., Lues, I., Caldarone, B. J., Schilling, S., Demuth, H., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.021 · Cited by 64
Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?
Fantini, J., Chahinian, H., & Yahi, N. (2020) · Protein Science · doi:10.1002/pro.3906 · Cited by 63
Umeda, T., Ramser, E. M., Yamashita, M., Nakajima, K., Mori, H., Silverman, M. A., & Tomiyama, T. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0230-2 · Cited by 70
Clioquinol and other hydroxyquinoline derivatives inhibit Aβ(1–42) oligomer assembly
LeVine, H., Ding, Q., Walker, J. A., Voss, S. R., & Augelli‐Szafran, C. E. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.08.002 · Cited by 66
Prince, S., Paulson, A. L., Jeong, N., Zhang, L., Amigues, S., & Singer, A. C. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109008 · Cited by 61
Auffret, A., Gautheron, V., Repici, M., Kraftsik, R., Mount, H. T. J., Mariani, J., & Rovira, C. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1856-09.2009 · Cited by 62
Tamayev, R., Matsuda, S., Fà, M., Arancio, O., & D'adamio, L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011689107 · Cited by 61
Self-citationRole of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes
Rapôso, C., Luna, R. L. D. A., Nunes, A. K. S., Thomé, R., & Peixoto, C. A. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.04.002 · Cited by 59
Lawrence, J. L. M., Tong, M., Alfulaij, N., Sherrin, T., Contarino, M., White, M. M., Bellinger, F. P., Todorovic, C., & Nichols, R. A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0326-14.2014 · Cited by 60
Effects of different amyloid β-protein analogues on synaptic function
Ripoli, C., Piacentini, R., Riccardi, E., Leone, L., Puma, D. D. L., Bitan, G., & Grassi, C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.027 · Cited by 62
Nicholls, R. E., Sontag, J.-M., Zhang, H., Staniszewski, A., Yan, S., Kim, C. Y., Yim, M., Woodruff, C. M., Arning, E., Wasek, B., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521018113 · Cited by 56
Self-citationPhysiological Role of Amyloid Beta in Neural Cells: The Cellular Trophic Activity
Cárdenas‐Aguayo, M. D. C., Silva‐Lucero, M., Cortés-Ortiz, M., Jimnez-Ramos, B., Gomez‐Virgilio, L., Ramrez-Rodrguez, G., Arroyo, E. V., Fiorentino-Prez, R., Garca, U., Luna-Muoz, J., et al. (2014) · InTech eBooks · doi:10.5772/57398 · Cited by 67
Wang, H., Megill, A., He, K., Kirkwood, A., & Lee, H. (2012) · Neural Plasticity · doi:10.1155/2012/272374 · Cited by 66
Khan, G. M., Tong, M., Jhun, M., Arora, K., & Nichols, R. A. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07116.x · Cited by 59
A Novel Nicotinic Mechanism Underlies β-Amyloid-Induced Neuronal Hyperexcitation
Liu, Q., Xie, X., Lukas, R. J., John, P. A. S., & Wu, J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3235-12.2013 · Cited by 64
Developing therapeutic vaccines against Alzheimer’s disease
Wısnıewskı, T., & Drummond, E. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1121815 · Cited by 60
Hascup, K. N., & Hascup, E. R. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160041 · Cited by 57
Initiative, A. D. N., Teipel, S. J., & Grothe, M. J. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3222-3 · Cited by 57
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer’s Disease Therapeutics
Jeong, H., Shin, H., Hong, S., & Kim, Y. S. (2022) · Experimental Neurobiology · doi:10.5607/en22004 · Cited by 59
Nicotinic Receptors, Amyloid-β, and Synaptic Failure in Alzheimer’s Disease
Jürgensen, S., & Ferreira, S. T. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9237-0 · Cited by 59
The Concentration of Soluble Extracellular Amyloid-β Protein in Acute Brain Slices from CRND8 Mice
Waters, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015709 · Cited by 60
Ahmed, T., Zahid, S., Mahboob, A., & Farhat, S. M. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160325121145 · Cited by 60
Synaptic vesicle cycle and amyloid β: Biting the hand that feeds
Ovsepian, S. V., O’Leary, V. B., Záborszky, L., Ntziachristos, V., & Dolly, J. O. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.01.011 · Cited by 57
Role of Receptors in Relation to Plaques and Tangles in Alzheimer’s Disease Pathology
Sharma, K., Pradhan, S., Duffy, L. K., Yeasmin, S., Bhattarai, N., & Schulte, M. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312987 · Cited by 59
A New Player in the “Synaptopathy” of Alzheimer’s Disease – Arc/Arg 3.1
Kerrigan, T. L., & Randall, A. D. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00009 · Cited by 57
Hampel, H. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129003 · Cited by 57
Nitric oxide/cGMP/CREB pathway and amyloid-beta crosstalk: From physiology to Alzheimer’s disease
Tropea, M. R., Gulisano, W., Vacanti, V., Arancio, O., Puzzo, D., & Palmeri, A. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.11.022 · Cited by 55
Self-citationSynapses, synaptic activity and intraneuronal Aβ in Alzheimer’s disease
Tampellini, D. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00013 · Cited by 58
Deleterious effects of soluble amyloid-β oligomers on multiple steps of synaptic vesicle trafficking
Park, J., Jang, M., & Chang, S. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.03.004 · Cited by 57
Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine
Klyubin, I., Wang, Q., Reed, M. N., Irving, E. A., Upton, N., Hofmeister, J., Cleary, J. P., Anwyl, R., & Rowan, M. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.005 · Cited by 69
Al-Kuraishy, H. M., Jabir, M. S., Al-Gareeb, A. I., Albuhadily, A. K., Albukhaty, S., Sulaiman, G. M., & Batiha, G. E. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102119 · Cited by 58
Sadigh‐Eteghad, S., Majdi, A., Mahmoudi, J., Golzari, S. E., & Talebi, M. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1580-z · Cited by 53
Emerging role of amyloid beta in stress response: Implication for depression and diabetes
Morgese, M. G., Schiavone, S., & Trabace, L. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.08.031 · Cited by 54
Peineau, S., Rabiant, K., Pierrefiche, O., & Potier, B. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.018 · Cited by 56
Tau is not necessary for amyloid-β–induced synaptic and memory impairments
Puzzo, D., Argyrousi, E. K., Staniszewski, A., Zhang, H., Calcagno, E., Zuccarello, E., Acquarone, E., Fà, M., Puma, D. D. L., Grassi, C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137040 · Cited by 53
Self-citationEntorhinal cortical defects in Tg2576 mice are present as early as 2–4 months of age
Duffy, Á., Morales‐Corraliza, J., Bermudez‐Hernandez, K., Schaner, M. J., Magagna‐Poveda, A., Mathews, P. M., & Scharfman, H. E. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.001 · Cited by 52
Takeda, A., Tamano, H., Tempaku, M., Sasaki, M., Uematsu, C., Sato, S., Kanazawa, H., Datki, Z., Adlard, P. A., & Bush, A. I. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0954-17.2017 · Cited by 53
Noradrenaline in the aging brain: Promoting cognitive reserve or accelerating Alzheimer's disease?
Mather, M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.05.013 · Cited by 57
Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease
Chiarini, A., Armato, U., Liu, D., & Dal Prà, I. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00134 · Cited by 51
Vaccination as a Therapeutic Approach to Alzheimer's Disease
Wısnıewskı, T., & Boutajangout, A. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20156 · Cited by 53
APP heterozygosity averts memory deficit in knockin mice expressing the Danish dementia BRI2 mutant
Tamayev, R., Matsuda, S., Giliberto, L., Arancio, O., & D'adamio, L. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.161 · Cited by 50
Self-citationAmyloid-Beta Mediates Homeostatic Synaptic Plasticity
Galanis, C., Fellenz, M., Becker, D., Bold, C. S., Lichtenthaler, S. F., Müller, U., Deller, T., & Vlachos, A. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1820-20.2021 · Cited by 56
Modeling an Anti-Amyloid Combination Therapy for Alzheimer’s Disease
Chow, V. W., Savonenko, A. V., Melnikova, T., Kim, H., Price, D. L., Li, T., & Wong, P. C. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000337 · Cited by 53
Tofighi, N., Asle‐Rousta, M., Rahnema, M., & Amini, R. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.06.002 · Cited by 50
Tong, M., Arora, K., White, M. M., & Nichols, R. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.241299 · Cited by 48
Environmental factors in the development and progression of late-onset Alzheimer’s disease
Wainaina, M. N., Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1425-9 · Cited by 53
Cerebrospinal Fluid Aβ42 Levels: When Physiological Become Pathological State
Martorana, A., Lorenzo, F. D., Belli, L., Sancesario, G., Toniolo, S., Sallustio, F., Sancesario, G. M., & Koch, G. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12476 · Cited by 51
Ohno, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.007 · Cited by 51
Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer’s Disease
Sellés, M. C., Oliveira, M. M., & Ferreira, S. T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179925 · Cited by 51
Sancheti, H., Patil, I., Kanamori, K., Brinton, R. D., Zhang, W. Y., Lin, A., & Cadenas, E. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.137 · Cited by 55
Wojtunik‐Kulesza, K. A., Rudkowska, M., Kasprzak‐Drozd, K., Oniszczuk, A., & Borowicz, K. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147366 · Cited by 51
Excitability and Synaptic Alterations in the Cerebellum of APP/PS1 Mice
Hoxha, E., Boda, E., Montarolo, F., Parolisi, R., & Tempia, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034726 · Cited by 49
Goñi, F., Prelli, F., Ji, Y., Scholtzova, H., Yang, J., Sun, Y., Liang, F., Kascsak, R., Kascsak, R. J., Mehta, P. D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013391 · Cited by 48
Bignante, E. A., Heredia, F., Morfini, G. A., & Lorenzo, A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.021 · Cited by 50
Ayton, S., & Bush, A. I. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101212 · Cited by 45
Lista, S., Vergallo, A., Teipel, S. J., Lemercier, P., Giorgi, F. S., Gabelle, A., Garaci, F., Mercuri, N. B., Babiloni, C., Gaire, B. P., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101819 · Cited by 47
The Potential Role of Rho GTPases in Alzheimer's Disease Pathogenesis
Bolognin, S., Lorenzetto, E., Diana, G., & Buffelli, M. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8637-5 · Cited by 47
George, A. A., Vieira, J. M., Xavier-Jackson, C., Gee, M. T., Cirrito, J. R., Bimonte‐Nelson, H. A., Picciotto, M. R., Lukas, R. J., & Whiteaker, P. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0876-20.2020 · Cited by 49
Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer’s Disease
Campos‐Peña, V., Pichardo-Rojas, P. S., Sánchez-Barbosa, T., Ortíz-Islas, E., Rodríguez-Pérez, C. E., Montes, P., Ramos-Palacios, G., Silva‐Adaya, D., Quintana, R. V., Cerna-Cortés, J. F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012092 · Cited by 47
Sehlin, D., Hedlund, M., Lord, A., Englund, H., Gellerfors, P., Paulie, S., Lannfelt, L., & Pettersson, F. E. (2010) · Neurodegenerative Diseases · doi:10.1159/000316530 · Cited by 47
Memantine prevents memory consolidation failure induced by soluble beta amyloid in rats
Tucci, P., Mhillaj, E., Morgese, M. G., Colaianna, M., Zotti, M., Schiavone, S., Cicerale, M., Trezza, V., Campolongo, P., Cuomo, V., et al. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00332 · Cited by 49
Development of new fusion proteins for visualizing amyloid-β oligomers in vivo
Ochiishi, T., Doi, M., Yamasaki, K., Hirose, K., Kitamura, A., Urabe, T., Hattori, N., Kinjo, M., Ebihara, T., & Shimura, H. (2016) · Scientific Reports · doi:10.1038/srep22712 · Cited by 46
Slater, C. L., & Wang, Q. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.397 · Cited by 47
Memory Deficits in Aging and Neurological Diseases
Khan, Z. U., Martín‐Montañez, E., Navarro‐Lobato, I., & Muly, E. C. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-420170-5.00001-5 · Cited by 48
C-Terminal Fragment, Aβ32–37, Analogues Protect Against Aβ Aggregation-Induced Toxicity
Bansal, S., Maurya, I. K., Yadav, N., Thota, C. K., Kumar, V., Tikoo, K., Chauhan, V. S., & Jain, R. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00006 · Cited by 45
Early Alterations of Hippocampal Neuronal Firing Induced by Abeta42
Gavello, D., Calorio, C., Franchino, C., Cesano, F., Carabelli, V., Carbone, E., & Marcantoni, A. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw377 · Cited by 45
Passive Aβ Immunotherapy: Current Achievements and Future Perspectives
Schilling, S., Rahfeld, J., Lues, I., & Lemere, C. A. (2018) · Molecules · doi:10.3390/molecules23051068 · Cited by 48
Rishton, G. M., Look, G. C., Ni, Z., Zhang, J. Y., Wang, Y., Huang, Y., Wu, X., Izzo, N. J., Mozzoni, K., Limegrover, C. S., et al. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00048 · Cited by 45
Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin
Parthasarathy, R., Chow, K. M., Derafshi, Z., Fautsch, M. P., Hetling, J. R., Rodgers, D. W., Hersh, L. B., & Pepperberg, D. R. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.06.027 · Cited by 44
Steele, J., Kim, S. H., Cirrito, J. R., Verges, D. K., Restivo, J. L., Westaway, D. A., Fraser, P., George‐Hyslop, P. S., Sano, M. C., Борисович, Б. И., et al. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-51 · Cited by 45
Amyloidosis in Retinal Neurodegenerative Diseases
Masuzzo, A., Dinet, V., Cavanagh, C., Mascarelli, F., & Krantic, S. M. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00127 · Cited by 45
What Is the “Relevant” Amyloid β42 Concentration?
Raskatov, J. A. (2019) · ChemBioChem · doi:10.1002/cbic.201900097 · Cited by 47
Kelschenbach, J., He, H., Kim, B., Borjabad, A., Gu, C., Chao, W., Do, M., Sharer, L. R., Zhang, H., Arancio, O., et al. (2019) · mBio · doi:10.1128/mbio.00591-19 · Cited by 43
Self-citationEmerging roles of N- and C-terminally truncated Aβ species in Alzheimer’s disease
Wirths, O., & Zampar, S. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1702972 · Cited by 44
Epilepsy, antiepileptic drugs and dementia
Beghi, E., & Beghi, M. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000802 · Cited by 44
Metadata
- Authors
- Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O.
- Affiliations
- Columbia University Irving Medical Center (US)
- University of Catania (IT)
- Columbia University (US)
- Corresponding author
- Arancio, Ottavio
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2008-12-31
- Volume
- 28
- Issue
- 53
- Pages
- 14537-14545
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2673049
- OpenAlex
- W2078917784
- Cited by
- 740
- References
- 56
- Citations by year
- 2026: 17 · 2025: 23 · 2024: 41 · 2023: 38 · 2022: 40 · 2021: 45 · 2020: 49 · 2019: 44 · 2018: 38 · 2017: 46 · 2016: 46 · 2015: 50 · 2014: 51 · 2013: 42 · 2012: 44
- FWCI
- 28.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- Funders
- Alzheimer's Association (NIRG-07-59597)
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS040045, R01NS049442, NS049442)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Keywords
- amyloid-beta, synaptic plasticity, long-term potentiation, hippocampus, memory, fear memory, contextual fear, alpha7 nicotinic acetylcholine receptor, Alzheimer's disease, amyloid-beta oligomers, neurotransmission
- MeSH terms
- Analysis of Variance, Animals, Bungarotoxins, Dose-Response Relationship, Drug, Electric Stimulation, Hippocampus, Humans, Male, Mecamylamine, Memory, Mice, Inbred C57BL, Neuronal Plasticity, Peptide Fragments, Receptors, Nicotinic, Synapses, 2-Amino-5-phosphonovalerate, Amyloid beta-Peptides, Mice, Knockout, Patch-Clamp Techniques, Excitatory Amino Acid Antagonists, Nicotinic Antagonists, Maze Learning, Excitatory Postsynaptic Potentials, Mice, alpha7 Nicotinic Acetylcholine Receptor, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
